Related references
Note: Only part of the references are listed.H5N1 avian influenza re-emergence of Lake Communication Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation
Guihua Wang et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007
Wai Lan Wu et al.
JOURNAL OF VIROLOGY (2008)
The growth and potential of human antiviral monoclonal antibody therapeutics
Wayne A. Marasco et al.
NATURE BIOTECHNOLOGY (2007)
Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using
Nikolai V. Kaverin et al.
JOURNAL OF VIROLOGY (2007)
Treatment with convalescent plasma for influenza A (H5N1) infection
Boping Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
H5N1 infection of the respiratory tract and beyond: a molecular pathology study
Jiang Gu et al.
LANCET (2007)
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006
Endang R. Sedyaningsih et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
Cameron P. Simmons et al.
PLOS MEDICINE (2007)
Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006
Aleksandr S. Lipatov et al.
EMERGING INFECTIOUS DISEASES (2007)
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza a infection in children
Norio Sugaya et al.
CLINICAL INFECTIOUS DISEASES (2007)
WHO rapid advice guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
Holger J. Schunemann et al.
LANCET INFECTIOUS DISEASES (2007)
New strain of influenza A virus (H5N1), Thailand
Salin Chutinimitkul et al.
EMERGING INFECTIOUS DISEASES (2007)
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors
Shinya Yamada et al.
NATURE (2006)
Emergence and predominance of an H5N1 influenza variant in China
G. J. D. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
Brendon J. Hanson et al.
RESPIRATORY RESEARCH (2006)
H5N1 influenza viruses in Lao People's Democratic Republic
David A. Boltz et al.
EMERGING INFECTIOUS DISEASES (2006)
Qinghai-like H5N1 from domestic cats, northern Iraq
Samuel L. Yingst et al.
EMERGING INFECTIOUS DISEASES (2006)
Multiple introductions of H5N1 in Nigeria - Phylogenetic analysis reveals that this deadly virus first arrived in Africa from different sources
M. F. Ducatez et al.
NATURE (2006)
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam
G. J. D. Smith et al.
VIROLOGY (2006)
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia
Chung-Lam Cheung et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab′)2 in mice
Jiahai Lu et al.
RESPIRATORY RESEARCH (2006)
Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control
H Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
H5N1 outbreaks and enzootic influenza
RG Webster et al.
EMERGING INFECTIOUS DISEASES (2006)
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia
KS Li et al.
NATURE (2004)
Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants
NV Kaverin et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR
Y Guan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
LV Gubareva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
IA Leneva et al.
ANTIVIRAL RESEARCH (2000)
Share Paper
